ArticleFrontiers in public health2025
Determinants of hospitalization expenditure for pediatric congenital heart disease: a single-center study from Xinjiang, China.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to identify key determinants of hospitalization costs for children aged 0-14 years with congenital heart disease (CHD) at a tertiary hospital in Xinjiang, China, to provide evidence for reducing the financial burden on families and improving health insurance policies. Methods: We conducted a retrospective analysis of medical records from 2,811 pediatric patients who underwent CHD surgery between September 2013 and September 2024. Potential influencing factors were screened using non-parametric tests, and mediating effects were examined through the Bias-Corrected Bootstrap method with 5,000 repetitions. Path analysis modeling was performed with AMOS 24.0 to clarify direct and indirect pathways among variables affecting hospitalization costs. Results: Median hospitalization costs for CHD patients showed an initial increase followed by a progressive decline, with sustained reduction after 2019. Costs for open-heart surgery consistently exceeded those for interventional procedures, with the former dominated by treatment fees and the latter primarily composed of material costs. Several factors were significantly associated with higher costs, including age under 2 years, absence of health insurance, complex CHD, open-heart surgery, and hospital stays lasting 20 days or longer (all Conclusion: Multiple clinical and socioeconomic factors influence hospitalization costs for children with CHD. To minimize the risk of catastrophic health expenditures for families, we recommend prioritizing interventional procedures, optimizing insurance reimbursement strategies, and enhancing awareness and enrollment in neonatal health insurance programs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.